Shilpa Medicare Ltd (SHILPAMED) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 780523, "name": "Shilpa Medicare", "stock_name": "Shilpa Medicare", "full_name": "Shilpa Medicare Ltd", "name_url": "stocks-analysis/shilpa-medicare", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "345.30", "chg": 7.3, "chgp": "2.16%", "dir": 1, "prev_price": "338.00", "mcapval": "6,760.00 Cr", "mcap": "Small Cap", "scripcode": 530549, "symbol": "SHILPAMED", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE790G01031", "curr_date": "Mar 25", "curr_time": "", "bse_nse_vol": "11.47 lacs", "exc_status": "Active", "traded_date": "Mar 25, 2026", "traded_date_str": "2026 03 25", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shilpa-medicare-780523-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Shilpa Medicare Ltd Surges 8.07% to Day's High of Rs 333.7 — Outperforms Sector by 6.47 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-hits-intraday-high-with-807-surge-on-24-mar-2026-3910415", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ShilpaMedicareL_priceRelatedfactors_3910415.png", "date": "2026-03-24 12:01:01", "description": "The Sensex declined by 1.34% on 24 Mar 2026, while Shilpa Medicare Ltd surged 8.07%, outperforming its Pharmaceuticals & Biotechnology sector by 6.47 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market environment." }, { "title": "Shilpa Medicare Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-is-rated-sell-3905898", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ShilpaMedicareL_mojoScore_3905898.png", "date": "2026-03-23 10:10:16", "description": "Shilpa Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Shilpa Medicare Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-is-rated-sell-3905865", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ShilpaMedicareL_mojoScore_3905865.png", "date": "2026-03-22 10:10:24", "description": "Shilpa Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Shilpa Medicare Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-is-rated-sell-3884862", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ShilpaMedicareL_mojoScore_3884862.png", "date": "2026-03-11 10:10:33", "description": "Shilpa Medicare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 February 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 11 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Shilpa Medicare Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-is-rated-sell-3862109", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShilpaMedicareL_mojoScore_3862109.png", "date": "2026-02-28 10:10:14", "description": "Shilpa Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Shilpa Medicare Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-is-rated-sell-3844157", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShilpaMedicareL_mojoScore_3844157.png", "date": "2026-02-17 10:10:38", "description": "Shilpa Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 February 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Shilpa Medicare Gains 3.74%: 5 Key Factors Driving the Week’s Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-gains-374-5-key-factors-driving-the-weeks-volatility-3839738", "imagepath": "", "date": "2026-02-14 15:03:20", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Feb 09:</strong> Intraday high surge to Rs.359.95 with a 14.47% gap up</p>\n <p><strong>Feb 09:</strong> Very positive quarterly financial results reported</p>\n <p><strong>Feb 11-12:</strong> Consecutive declines amid technical caution</p>\n <p><strong>Feb 13:</strong> Modest recovery to close the week at Rs.326.20</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.314.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.326.20</div..." }, { "title": "Shilpa Medicare Ltd Hits Intraday High with 7.33% Surge on 9 Feb 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-hits-intraday-high-with-733-surge-on-9-feb-2026-3828494", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShilpaMedicareL_priceRelatedfactors_3828494.png", "date": "2026-02-09 10:13:00", "description": "Shilpa Medicare Ltd recorded a robust intraday performance on 09 Feb 2026, surging to a day’s high of Rs 359.95, marking a significant 7.33% gain. The pharmaceutical and biotechnology company outpaced its sector and the broader market, reflecting heightened trading activity and volatility." }, { "title": "Shilpa Medicare Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-3828129", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShilpaMedicareL_gapup_3828129.png", "date": "2026-02-09 09:31:03", "description": "Shilpa Medicare Ltd commenced trading today with a significant gap up, opening 14.47% higher than its previous close, signalling robust positive sentiment in the Pharmaceuticals & Biotechnology sector. This strong start was accompanied by heightened volatility and outperformance relative to both its sector and the broader market indices." } ], "total": 378, "sid": "780523", "stock_news_url": "https://www.marketsmojo.com/news/shilpa-medicare-780523" }, "announcements": [ { "details": "Shilpa Medicare Limited has informed the Exchange regarding Disclosure of Related Party Transaction disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.", "source": "NSE", "caption": "Shilpa Medicare Limited - Other General Purpose", "datetime": "03-Dec-2019" }, { "details": "Shilpa Medicare Limited has informed the Exchange regarding Board meeting held on November 09, 2019.", "source": "NSE", "caption": "Shilpa Medicare Limited - Outcome of Board Meeting", "datetime": "13-Nov-2019" }, { "details": "Shilpa Medicare Limited has informed the Exchange regarding ''.", "source": "NSE", "caption": "Shilpa Medicare Limited - Updates", "datetime": "06-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Shilpa Medicare Ltd has declared <strong>100%</strong> dividend, ex-date: 17 Sep 25", "dt": "2025-09-17", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Shilpa Medicare Ltd has announced <strong>1:2</strong> stock split, ex-date: 06 Nov 15", "dt": "2015-11-06", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Shilpa Medicare Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 03 Oct 25", "dt": "2025-10-03", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Feb 09: Intraday high surge to Rs.359.95 with a 14.47% gap up

Feb 09: Very positive quarterly financial results reported

Feb 11-12: Consecutive declines amid technical caution

Feb 13: Modest recovery to close the week at Rs.326.20

Week Open

Rs.314.45

Week Close

Rs.326.20Read full news article

Shilpa Medicare Ltd Hits Intraday High with 7.33% Surge on 9 Feb 2026

2026-02-09 10:13:00

Shilpa Medicare Ltd recorded a robust intraday performance on 09 Feb 2026, surging to a day’s high of Rs 359.95, marking a significant 7.33% gain. The pharmaceutical and biotechnology company outpaced its sector and the broader market, reflecting heightened trading activity and volatility.

Read full news article

Shilpa Medicare Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment

2026-02-09 09:31:03

Shilpa Medicare Ltd commenced trading today with a significant gap up, opening 14.47% higher than its previous close, signalling robust positive sentiment in the Pharmaceuticals & Biotechnology sector. This strong start was accompanied by heightened volatility and outperformance relative to both its sector and the broader market indices.

Read full news article